It has been a very scary flu season this year as some people, young and old, have lost their lives to the virus. Japan has recently given the green light to a drug called Xofluza that promises to kill the flu virus in 24 hours. Officials in Japan approved the single dose drug, which is … Continue reading “Japan Just Approved a Drug That Promises to Kill Flu in Only 24 Hours”
Biotech & Pharma
Allergan Smashes in its Earnings Report
Biopharma company Allergan has reported stellar fourth-quarter adjusted earnings. The company also revealed that the…
Warren Buffet, Jeff Bezos, and Jamie Dimon are Shaking up the Healthcare Industry
One of the biggest headlines on Tuesday was the announcement that Amazon's CEO Jeff Bezos,…
Sanofi is Closing a Deal to Buy This U.S. Drug Maker
Reported on Monday by the Wall Street Journal which cited people who are close to…
Gilead Sciences Will Collaborate with Pfizer Over This Therapy
It was announced this week that Kite Pharma Inc., a subsidiary of Gilead Sciences, has…
Spark Therapeutics Can Cure Rare Blindness For $850,000
Spark Therapeutics' Luxturna is a gene therapy that treats a rare inherited retinal disease that…
Trevena Soars on FDA News Over Opioid Replacement Pain Killer
Trevena shares were on fire in after hours trading on Tuesday after the biotech company…
The FDA Has Approved Spark Therapeutics’ Luxturna Therapy
In what is the first in the field of gene therapy, Spark Therapeutics' Luxturna has…
Sage Therapeutics Shares Skyrocket on Positive Depression Drug Trial Results
Shares of Sage Therapeutics were climbing fast on Thursday after the company announced positive mid-stage…
Neuralstem Explodes on Positive Phase 2 Clinical Data
Shares of Neuralstem were exploding in Tuesday trading and closed the day up 175% after…
First Digital Pill is Approved by the FDA
There's now a way for doctors to truly know if a patient has taken their…
Novartis to Buy This Big French Drug Maker for $3.9 Billion
Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French…
Pfizer to Sell its Consumer Healthcare Business in November
According to a Reuters report which cited two people close to the matter who remain…
Novartis Climbs Higher After Earnings Rise
Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after…